Express News | FibroBiologics To Join Russell 2000 Index; Effective July 1 Following Annual Reconstitution
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersViracta Therapeutics (NASDAQ:VIRX) stock increased by 16.8% to $0.68 during Tuesday's pre-market session. The company's market cap stands at $26.7 million. Purple Biotech (NASDAQ:PPBT) stock in
Vail Resorts Posts Downbeat Q3 Results, Joins Concrete Pumping, DocuSign And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 0.1% on Friday.Shares of Vail Resorts, Inc. (NYSE:MTN) fell sharply in today's pre-market trading after the co
FibroBiologics Shares Up 38% on Withdrawn Equity Offering
By Josh Beckerman FibroBiologics shares rose Thursday after the cell therapy and regenerative medicine company said it will no longer pursue a planned equity offering. The stock was up 38% to $9.24
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersVirax Biolabs Group (NASDAQ:VRAX) shares rose 88.8% to $2.02 during Thursday's regular session. The company's market cap stands at $4.7 million. FibroBiologics (NASDAQ:FBLG) shares rose 45.37%
Express News | FibroBiologics Shares Are Trading Higher After the Company in a FormRW Disclosed That Its Registration Statement Has Not Been Declared Effective by the SEC and No Securities Have Been Issued or Sold Under the Registration Statement
Express News | FibroBiologics Shares Resume Trade
FibroBiologics Determined Not to Pursue Public Offering and Will Consider Other Alternatives
FibroBiologics Determined Not to Pursue Public Offering and Will Consider Other Alternatives
FibroBiologics Withdraws Registration Statement on Form S-1 Initially Filed With SEC on April 26
FibroBiologics Withdraws Registration Statement on Form S-1 Initially Filed With SEC on April 26
Express News | FibroBiologics Shares Halted On Circuit Breaker To The Upside, Stock Now Up 25.8%
Express News | FibroBiologics Files FormRW, Registration Statement Has Not Been Declared Effective By The Commission, And No Securities Have Been Issued Or Sold Under The Registration Statement; Shares Spike Higher
FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024
HOUSTON, June 06, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersENDRA Life Sciences (NASDAQ:NDRA) stock increased by 79.2% to $0.15 during Wednesday's regular session. The company's market cap stands at $1.6 million. Rezolute (NASDAQ:RZLT) stock moved upwar
Press Release: FibroBiologics Announces 2024 Annual Meeting of Stockholders
FibroBiologics Announces 2024 Annual Meeting of Stockholders HOUSTON, May 15, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company w
FibroBiologics 1Q Loss/Shr 27c >FBLG
FibroBiologics 1Q Loss/Shr 27c >FBLG
FibroBiologics | 10-Q: Quarterly report
FibroBiologics to Present at the BIO International Convention 2024
HOUSTON, May 07, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of
FibroBiologics Files to Sell 1.8M Units
Express News | Fibrobiologics Files for Offering of up to 1.8 Mln Units, Each Consisting of One Common Share, One Warrant to Purchase One Common Share - SEC Filing
FibroBiologics, Charles River Laboratories Sign Letter Of Intent Allowing For Transfer, Testing And Validation Of Technology
This agreement comes ahead of entering into an anticipated master services agreement for the development and manufacture of FibroBiologics' master cell bank, working cell bank, and fibroblast-based sp
No Data